Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.389
Peer-review started: January 18, 2016
First decision: February 29, 2016
Revised: April 4, 2016
Accepted: May 7, 2016
Article in press: May 9, 2016
Published online: June 24, 2016
Processing time: 158 Days and 0.2 Hours
AIM: To determine the incidence, etiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients undergoing orthotopic liver transplantation (OLT).
METHODS: This retrospective study considered 242 patients undergoing deceased donor OLT. VAP was diagnosed according to clinical and microbiological criteria.
RESULTS: VAP occurred in 18 (7.4%) patients, with an incidence of 10 per 1000 d of mechanical ventilation (MV). Isolated bacterial etiologic agents were mainly Enterobacteriaceae (79%). Univariate logistic analysis showed that model for end-stage liver disease (MELD) score, pre-operative hospitalization, treatment with terlipressin, Child-Turcotte-Pugh score, days of MV and red cell transfusion were risk factors for VAP. Multivariate analysis, considering significant risk factors in univariate analysis, demonstrated that pneumonia was strongly associated with terlipressin usage, pre-operative hospitalization, days of MV and red cell transfusion. Mortality rate was 22% in the VAP group vs 4% in the group without VAP.
CONCLUSION: Our data suggest that VAP is an important cause of nosocomial infection during postoperative period in OLT patients. MELD score was a significant risk factor in univariate analysis. Multiple transfusions, treatment with terlipressin, preoperative hospitalization rather than called to the hospital while at home and days of MV constitute important risk factors for VAP development.
Core tip: Ventilator associated pneumonia (VAP) is a serious perioperative complication in liver transplant recipients, and its etiology and risk factors are still poorly understood. Therefore, we conducted this retrospective study in a big sample of patients to evaluate the incidence, risk factors, etiological agents and outcome of VAP considering 242 consecutive liver transplant recipients. VAP occurred with an incidence of 10 per 1000 d of mechanical ventilation (MV). Multivariate analysis demonstrated that VAP was strongly associated with terlipressin usage, pre-operative hospitalization, days of MV and red cell transfusion. Mortality rate was 22% in the VAP group vs 4% in the group without VAP.